The role of diffusion and perfusion magnetic resonance imaging in differentiation of haemangioblastomas and pilocytic astrocytomas
More details
Hide details
Submission date: 2018-04-05
Acceptance date: 2018-04-06
Publication date: 2018-05-10
Pol J Radiol, 2018; 83: 197-203
Haemangioblastomas (HABLs) and pilocytic astrocytomas (PAs) are brain tumours presenting similar appearance and location in conventional magnetic resonance (MR) imaging. The purpose of our study was to determine whether a detailed analysis of diffusion (DWI) and perfusion (PWI) characteristics can be useful in preoperative differentiation of these tumours.

Material and methods:
The study group consisted of biopsy proven six HABLs and six PAs, which underwent preoperative standard MR examinations including PWI and DWI. In PWI relative cerebral blood volume (rCBV) and the shape of perfusion curves (parameters of peak height – rPH and percentage of signal recovery – rPSR) were analysed. All perfusion parameters were measured for the entire tumour core (mean rCBV, mean rPH, mean rPSR) and in regions with maximal values (max rCBV, max rPH, max rPSR). In DWI parameters of apparent diffusion coefficient (ADC) from the entire tumour core (mean ADC) and in regions with minimal values (min ADC) were evaluated.

Compared to PAs, HABLs presented significantly higher rCBV and rPH values and lower mean rPSR value. PAs showed significantly lower rCBV and rPH values and higher mean rPSR value. Mean rCBV showed no overlap in the values between HABLs and PAs, and thus it provided the highest accuracy in differentiating between them. Max rPSR, mean ADC, and min ADC did not show any significant differences.

High rCBV values and deep perfusion curves with only partial return to the baseline are characteristic features of HABLs differentiating them from PAs, which show lower rCBV values and perfusion curves overshooting the baseline. Diffusion parameters are not useful in differentiation of these tumours.

Stüer C, Vilz B, Majores M, et al. Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 2007; 110: 2799-2808.
Burkhard C, Di Patre PL, Schuler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 2003; 98: 1170-1174.
Brundl E, Schodel P, Ullrich OW, et al. Surgical resection of sporadic and hereditary hemangioblastoma: Our 10-year experience and a literature review. Surg Neurol Int 2014; 5: 138.
Osborn AG, Hedlund G, Salzman KL. Osborn’s Brain, Second Edition. Elsevier, Philadelphia 2017.
Koeller KK, Rushing EJ. From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 2004; 24: 1693-1708.
Kumar VA, Knopp EA, Zagzag D. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: Initial results. J Comput Assist Tomogr 2010; 34: 825-829.
Padhi S, Sarangi R, Challa S, et al. A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease. J Clin Neurosci 2017; 18: 939-944.
She D, Yang X, Xing Z, et al. Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging. AJNR Am J Neuroradiol 2016; 37: 1844-1850.
Essig M, Shiroishi MS, Nguyen TB, et al. Perfusion MRI: The five most frequently asked technical questions. Am J Roentgenol 2013; 200: 24-34.
Zimny A, Sasiadek M. Contribution of perfusion-weighted magnetic resonance imaging in the differentiation of meningiomas and other extra-axial tumors: case reports and literature review. J Neurooncol 2011; 103: 777-783.
Kang Y, Choi SH, Kim YJ, et al. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging – correlation with tumor grade. Radiology 2011; 261: 882-890.
Murakami R, Hirai T, Kitajima M, et al. Magnetic resonance imaging of pilocytic astrocytomas: Usefulness of the minimum Apparent Diffusion Coefficient (ADC) value for differentiation from high-grade gliomas. Acta Radiol 2008; 49: 462-467.
Bing F, Kremer S, Lamalle L, et al. Intéręt de l’imagerie de perfusion dans l’étude des astrocytomes pilocytiques et des hémangioblastomes: étude préliminaire. J Neuroradiol 2009; 36: 82-87.
She DJ, Xing Z, Zeng Z, et al. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy. Neuroradiology 2015; 57: 275-281.
Mangla R, Kolar B, Zhu T, et al. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. Am J Neuroradiol 2011; 32: 1004-1010.
Quadery F, Okamoto K. Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours. Neuroradiology 2003; 45: 212-219.
de Fatima Vasco Aragao M, Law M, Batista de Almeida D, et al. Comparison of perfusion, diffusion, and mr spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas. AJNR Am J Neuroradiol 2014; 35: 1495-1502.
Schneider JF, Confort‐Gouny S, Viola A et al. Multiparametric differentiation of posterior fossa tumors in children using diffusion‐weighted imaging and short echo‐time 1H‐MR spectroscopy. J Magn Reson Imaging 2007; 26: 1390-1398.
Journals System - logo
Scroll to top